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A B S T R A C T
Extracorporeal membrane oxygenation (ECMO) has been used successfully for the treatment of patients
with respiratory failure due to severe infections. Although rare, parasites can also cause severe
pulmonary disease. Tapeworms of the genus Echinococcus give rise to the development of cystic
structures in the liver, lungs, and other organs. Acute cyst rupture leads to potentially life-threatening
infection, and affected patients may deteriorate rapidly. The case of a young woman from Bulgaria who
was admitted to hospital with severe dyspnoea, progressive chest pain, and haemoptysis is described.
Computed tomography of the chest was pathognomonic for cystic echinococcosis with acute cyst
rupture. Following deterioration on mechanical ventilation, she was cannulated for veno-venous ECMO.
The patient’s condition improved considerably, and she was weaned successfully from ECMO and
mechanical ventilation. Following lobectomy of the affected left lower lobe, the patient was discharged
home in good condition. This appears to be the ﬁrst report of the successful use of ECMO as salvage
treatment for a severe manifestation of a helminthic disease. Due to recent migration to Western Europe,
the number of patients presenting with respiratory failure due to pulmonary echinococcosis with cyst
rupture is likely to increase.
© 2017 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
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Tapeworms of the genus Echinococcus can cause severe human
infections with a potentially fatal course (Eckert and Deplazes,
2004). Cystic echinococcosis and alveolar echinococcosis represent
the two main clinical entities and are caused by Echinococcus
granulosus and Echinococcus multilocularis, respectively. The
development of cystic structures in the liver, lungs, and other
organs is the key feature of echinococcosis. While the main burden
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across Europe, with E. granulosus being frequent in some
Mediterranean countries and Southeast Europe (e.g. Bulgaria,
Romania) and E. multilocularis being highly endemic in France,
southern Germany, Austria, Switzerland, and Turkey (Eckert and
Deplazes, 2004). Recently, a steady increase in cases has been
reported from a number of European countries, but clinician
awareness of the infection is usually low and treatment practices
may vary considerably, even in specialised centres (Nabarro et al.,
2015).
Extracorporeal membrane oxygenation (ECMO) is an extracor-
poreal technique that can provide temporary life support to
patients with severe respiratory or cardiac failure (Makdisi and
Wang, 2015). ECMO can be used for severe acute respiratory
distress syndrome (ARDS) and any forms of potentially reversible
respiratory insufﬁciency as ‘bridge-to-recovery’ or ‘bridge-to-ciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
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With regard to its use as salvage treatment for severe respiratory
infections, a recently published systematic review and meta-
analysis conﬁrmed the role of ECMO as an adjunct for severe
inﬂuenza A H1N1 pneumonia (Vaquer et al., 2017). However, it
appears that no reports on the potential use of ECMO in the
treatment of parasitic worm infections have been published to
date.
Case report
A 23-year-old female patient from Bulgaria was admitted to a
local hospital in southwest Germany because of progressive
dyspnoea and chest pain. The patient had lived in Germany for
several years and her past medical history was unremarkable
except for being a former smoker (cumulative dose of ﬁve pack-
years). Upon admission, the patient reported having had mild chest
pain during the four preceding weeks. She also reported one
episode of haemoptysis on the day of presentation. On clinical
examination, no fever was noted and the patient’s peripheral
oxygen saturation was 83%. Initial blood gas analysis revealed a pO2
of 44 mmHg and laboratory investigations showed considerably
increased inﬂammatory markers with an elevated C-reactive
protein (CRP) level of 56 mg/l (normal value <5 mg/l). On chest
X-ray, a large cystic structure was seen in the left hemithorax.
The patient’s condition deteriorated rapidly and she was
admitted to the intensive care unit with a preliminary diagnosis
of community-acquired pneumonia with a large abscess. Blood
cultures and sputum samples were obtained for microbiological
investigations, and empirical antibiotic treatment with
piperacillin–tazobactam was started. A computed tomography
(CT) scan of the thorax was performed, which showed one large,
partially ﬂuid-ﬁlled cystic structure (measuring 11 5.6  9.2 cm)
in the left hemithorax that appeared to be septated and comprised
several endocysts (Figure 1). Several freely ﬂoating membranes
within the endocysts were seen (known as ‘water-lily sign’), a
ﬁnding highly suggestive of pulmonary echinococcosis.
The patient’s condition continued to decline and she developed
worsening hypoxia. Therefore, she was transferred to the Saarland
University Medical Centre in Homburg, Germany. Upon arrival, the
patient was in septic shock and respiratory failure, necessitating
aggressive ﬂuid resuscitation, vasopressor treatment, intubation
and mechanical ventilation. The antibiotic regimen was changed to
a carbapenem (meropenem 1 g three times a day) and vancomycin
(1 g two times a day on the ﬁrst day, then adjusted to serum levels).Figure 1. Computed tomography scan of the patient with pulmonary echinococ-
cosis, showing a large, partially ﬂuid-ﬁlled cyst in the left lower lobe, in which freely
ﬂoating membranes of smaller endocysts can be seen (red arrow; so-called ‘water-
lily sign’).Serology for anti-Echinococcus antibodies was positive and chest X-
rays showed ﬁndings suggestive of acute rupture of the cystic
structure in the left lower lobe. Albendazole (400 mg two times a
day) was added to the anti-infective regimen. A new bronchial
aspirate obtained on mechanical ventilation grew Haemophilus
inﬂuenzae, which was sensitive to both meropenem and
piperacillin–tazobactam.
The patient’s condition worsened further and she developed
progressive hypoxic and hypercapnic respiratory failure with
respiratory acidosis (pO2 44 mmHg, pCO2 79 mmHg, pH 7.21, pO2/
FiO2 index 70). At this point, the patient was felt to have ARDS due
to bacterial superinfection of a ruptured Echinococcus cyst in the
left hemithorax. Given her progressive deterioration and ongoing
clinical instability, the decision was made to initiate veno-venous
ECMO support. Cannulation of the right femoral vein and the right
internal jugular vein was performed and ECMO treatment was
initiated.
After 7 days on ECMO support, the patient’s condition improved
considerably; she was weaned off vasopressors and her inﬂam-
matory markers normalised. The patient was then weaned off
ECMO and she was extubated 3 days later. After further clinical
improvement, the patient underwent a left lower lobectomy for
surgical treatment of the residual cystic structure. Speciﬁc PCR
assays on the resected tissue conﬁrmed the presence of nucleic
acids of E. granulosus. The postoperative course was uncomplicated
and no signs of further organ involvement of the echinococcosis
were found. The patient was discharged home in good condition,
with plans to continue oral albendazole treatment for at least
2 years.
Discussion
This case describes the use of ECMO as salvage treatment for
severe respiratory insufﬁciency due to pulmonary E. granulosus
infection with acute cyst rupture and bacterial superinfection,
possibly for the ﬁrst time. ECMO has been used widely as a
treatment modality for severe respiratory failure and ARDS due to
viral (e.g., inﬂuenza A) and bacterial diseases (e.g., pneumococcal
pneumonia), as well as malaria (Alves et al., 2013). However, no
previous reports on its use in respiratory failure due to helminthic
diseases could be identiﬁed in the literature. With a steadily
increasing number of echinococcosis cases in Europe and in view
of a lack of awareness among clinicians, it is likely that many
patients will only be diagnosed at an advanced stage of disease
when they present with acute complications. Indeed, in 2015,
37.7% of all cases of echinococcosis in the European Union were
reported from Bulgaria alone, thereby underscoring the signiﬁcant
endemicity of this parasitic infection in Southeast Europe
(European Centre for Disease Prevention and Control, 2016). Thus,
echinococcosis should always be included in the differential
diagnosis of patients presenting with large, cyst-like lesions of the
lung or liver.
In the case described herein, the pathognomonic ‘water-lily’
pattern was noted on the CT scan of the chest. Serology and PCR
of the resected tissue conﬁrmed the aetiology in this case, but it
is important to note that no speciﬁc antibodies can be detected
in approximately 30% of all pulmonary Echinococcus cases.
Potential treatment modalities for echinococcosis include (1)
surgical resection (indicated for larger cysts measuring >10 cm;
complete resection may cure the disease); (2) a minimally
invasive treatment option called PAIR, i.e. puncture–aspiration–
injection–re-aspiration (which is particularly useful for treating
univesicular hepatic cysts); and (3) medical treatment (chemo-
therapy with the benzimidazoles albendazole or mebendazole,
both for inoperable cases and as an adjunct after surgery and
PAIR) (Eckert and Deplazes, 2004). Choosing the most
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echinococcosis is not trivial, and recent surveys revealed
signiﬁcant heterogeneity among treating clinicians worldwide,
who often did not follow the recommendations put forth by the
World Health Organization Informal Working Group on Echino-
coccosis (Nabarro et al., 2015).
Similar to the management of echinococcosis, survival rates and
outcomes of patients treated with ECMO are superior in specialised
centres with intensivists who have long-standing experience with
extracorporeal circuits and the management of complications such
as bleeding and thromboembolic events. Close cooperation
between intensivists and infectious disease experts is thus vital
to ensure optimal patient outcomes.
In conclusion, this case demonstrates the feasibility and utility
of ECMO therapy as a salvage ‘bridge-to-recovery’ treatment
modality for severe respiratory failure due to a helminthic
infection.Conﬂict of interest/funding
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